DATE – Page 10 – Talk Bio

Exact Sciences Advances Toward FDA Submission with Promising Blood-Based Colorectal Cancer Screening Test

7 months ago talkbio0Tagged blood-based colorectal cancer, Colorectal Carcinoma, Detection, ESMO, Exact Sciences, precancerous lesions, Submission, United States Food and Drug Administration

Exact Sciences, Blood-Based Colorectal Cancer Screening, ESMO 2024, FDA Submission, Colorectal Cancer Detection, Advanced Precancerous Lesions

ESMO 2023: Merck’s Welireg Demonstrates Sustained PFS Benefit in Advanced Renal Cell Carcinoma, Despite Ongoing OS Concerns

7 months ago talkbio0Tagged belzutifan, Co., ESMO, LITESPARK-005 trial, Overall Survival, Progression-Free Survival, Renal Cell Carcinoma, Welireg

Merck & Co., Welireg (belzutifan), ESMO 2023, Advanced Renal Cell Carcinoma (RCC), Progression-Free Survival (PFS), Overall Survival (OS), LITESPARK-005 trial

Biopharma Layoff Tracker 2024: Ongoing Industry Downsizing

8 months ago talkbio0Tagged 2024, Biopharma layoffs, Drug Industry, layoffs, Pharma

Biopharma layoffs, 2024 layoffs, pharmaceutical industry downsizing, biotech job cuts, pharma restructuring

Biopharma Layoff Tracker 2024: Industry Continues to Downsize Amid Economic Uncertainty

8 months ago talkbio0Tagged 2024, Biopharma layoffs, biotech, Drug Industry, Economics, Industry, layoffs, trends qualifier

Biopharma layoffs, 2024 layoffs, Pharmaceutical industry downsizing, Biotech industry trends, Economic uncertainty